ArticleScientific reports2021
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer.
Alessandro De Vita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papercites it